The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2015
DOI: 10.1016/j.yjmcc.2015.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Genetic variants associated with risk of atrial fibrillation regulate expression of PITX2, CAV1, MYOZ1, C9orf3 and FANCC

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
26
0
4

Year Published

2016
2016
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(32 citation statements)
references
References 49 publications
(54 reference statements)
2
26
0
4
Order By: Relevance
“…We speculate that this SNP may increase PITX2 expression and thereby decrease downstream cardiac channel gene regulatory network expression. This model is consistent with previously published work, in which AF risk SNPs at PITX2 are associated with increased PITX2 expression (28). …”
Section: Discussionsupporting
confidence: 93%
“…We speculate that this SNP may increase PITX2 expression and thereby decrease downstream cardiac channel gene regulatory network expression. This model is consistent with previously published work, in which AF risk SNPs at PITX2 are associated with increased PITX2 expression (28). …”
Section: Discussionsupporting
confidence: 93%
“…Besides, Chinchilla et al identified that PITX2c was significantly lower in patients with sustained AF [27]. In addition, Martin et al [28] found a strong association between variant rs2200733 and total expression of PITX2a in human atrial appendages. However, another study showed that although the variants were significantly associated with the risk of AF independently, neither of them was associated with PITX2c expression in human adult left atrial appendages [29].…”
Section: Discussionmentioning
confidence: 98%
“…The most extensively studied genetic factors implicated in the development of postoperative AF [20], or in symptomatic responses to antiarrhythmic drug therapy for chronic AF [47], are the noncoding polymorphisms near PITX2 in the chromosome 4q25 region. A recent study of patients who underwent cardiac surgery [48] showed cis -acting associations between risk SNPs at 4q25 and increased PITX2a isoform expression in atrial tissue. However, in our study we did not observe differential expression of PITX2 in RAA tissue, and variants in the gene showed only nominally significant trans- acting associations with VOPP1 .…”
Section: Discussionmentioning
confidence: 99%